Uganda Approves Injectable HIV Drug Amid Increasing Infections
Uganda has approved the long-lasting injectable HIV drug Cabotegravir, becoming the second African country to do so after Zimbabwe. The PrEP, or pre-exposure prophylaxis, treatment prevents the transmission of the virus. About 1.4 million people are living with HIV in Uganda, according to official data. Africa 54 health correspondent Linord Moudou spoke with Nelson Musoba, executive director of Uganda AIDS Commission, who cautioned against complacency, especially among young people.
Episodes
-
September 18, 2024
US-Africa leaders and entrepreneurs meet in New York City
-
September 17, 2024
Bill and Melinda Gates Foundation releases report on global malnutrition
-
September 16, 2024
Analysis: West African junta leaders ditch ECOWAS passports
-
September 15, 2024
Botnar Foundation launches Pediatric Immunity research department
-
September 14, 2024
Entertainment Report: Chardelle Moore debuts “Inward Awakening” album